Hikma Pharmaceutical reported $964M in Operating Expenses for its first fiscal semester of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Expenses Change
Artemis Alpha ATS:LN GBP 833K 39K
AstraZeneca AZN:LN USD 9.74B 495M
Bayer BAYN:GR EUR 10.08B 2.57B
Fresenius FRE:GR EUR 9.57B 399M
Fresenius Medical Care FMS:US EUR 4.62B 208.35M
Galapagos GLPG:NA EUR 185.62M 38.28M
Genmab GEN:DC DKK 2.16B 241M
GlaxoSmithKline GSK:LN GBP 5.51B 1.13B
Hikma Pharmaceutical HIK:LN USD 964M 118M
Merck MRK:GR EUR 4.57B 181M
Orion ORNBV:FH EUR 246.4M 44.7M
Recordati REC:IM EUR 362.35M 11.63M
Roche Holding ROG:VX 20.75B 3.26B